INSTRUCTIONS FOR AUTHORS
Health Biotechnology and Biopharma Journal(HBB) is a Quarterly peer-reviewed,which publishes original research papers,review articles and short communications on all areas of Biotechnology, Biopharma and Health including Pharmaceutical Biotechnology, Medical Biotechnology, Food Biotechnology, Bioinformatics, Scope of Biotechnology Education, Biotechnology in detecting rare Genetic Diseases and Biotechnology in Forensics. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions
Once you are sure you want to submit your article to a trusted journal that is publishing in the same field as your research, always carefully read that journal's instructions to authors guidelines document and edit your manuscript accordingly before submitting it to the journal. Many journals will reject your article immediately if you have not followed their instructions.
This Journal accepts only manuscripts through the online submission system. It is easy to use and easy to track, thus by conducting all steps electronically, your submission will be expedient. Contributors can submit via our website. Once you submit an article, it will be forwarded to one of the editors and afterwards to at least two peer-reviewers. The author will be notified of the submission process by means of E-mail.
This letter should be uploaded online as a word file. The author should state that the manuscript has not been and will not be published or submitted elsewhere. The financial disclosure should be declared. The letter must include a statement declaring that the study complies with current ethical considerations. Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that: (1) informed consent was obtained from each patient included in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
Manuscripts should be in Word Document (Microsoft Word 97, 2003, 2007, 2010, 2013) in English and should follow the style of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, a copy of which can be found at www.icmje.org.
Use the font Times New Roman size 12 for the body, size 12 bold for subheadings, size 14 for headings and size 14 bold for the title, Line spacing=Double.
Word Count Limits
• Short Articles: 1500 - 2000 words (Maximum number of references is 15, Maximum Number of illustrations/Tables is 2)
• Original Reports: 2500 - 3500 words (Maximum number of references is 40, Maximum Number of illustrations/Tables is 5)
• Review Articles: 3500 - 4000 words (Maximum number of references is 60, Maximum Number of illustrations/Tables is 5)
• Case Report: 1500 - 2000 words (Maximum number of references is 10, Maximum Number of illustrations/Tables is 2)
• Figure legends (including multiple figure parts): 55-75 words
• Acknowledgments (not including research funding): 45-55 words.
The following information should be included:
(a) A concise title
(b) The names of all authors
(c)The department, institution, and address at which the research was performed
(d) The number of text pages; tables; figures
(e) A short running head (40 characters or less)
(f) Grant numbers and resource (s) of support
(g) Name, address, e-mail, telephone and fax numbers of author to whom correspondence and proofs should be sent.
(h) Name and address of author to who reprint requests should be sent (if different from above).
Provide on a separate page an abstract of not more than120-140 words. A concise and factual abstract is required. The Abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, standard nomenclature should be used and abbreviations and references should be avoided.
Provide three to six appropriate keywords after the abstract.
Generally includes the: Background, Objectives, Materials/Patients and Methods, Results, Discussion, Conclusions and References.
This should summarize the rationale for the study.
State the aims of the study.
•Materials and Methods
It should be complete enough to allow experiments to be reproduced. All the procedures should be described in detail, previously published procedures should be cited, and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer's name and address. Subheadings should be used. Methods in general use need not be described in detail.
Results and their significance should be presented clearly and concisely, preferably in the form of graphs and tables which should be self explanatory.
It should contain a critical review of the results in the light of relevant literature. Results and Discussion may be combined.
This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.
All contributors who do not meet the criteria for authorship should be covered in the acknowledgment section. Persons who provided technical help, writing assistance and should also be acknowledged.
Figures must be submitted as separate files in the form of tiff (.tif), jpeg (.jpg), png (.png), or Photoshop (.psd). Authors should declare in the cover letter that all figures of their manuscripts are original. Resolution should be 300 dpi for a 3*2 inch figure.
•Units, Symbols, and Abbreviations
Internationally accepted units (International System of Units), symbols, and abbreviations must be used. Abbreviations should be used sparingly and must be introduced in parentheses upon the first mention.
Generic drug names must be used.
The authors are responsible for the accuracy of the bibliographic information. It must be numbered consecutively in the order that they are cited in the text and designated by superscript with square brackets after the punctuation marks. ([X]) A list should be included on separate 1.5spaced pages at the end of the text. The style and punctuation of the references should confirm to the following examples:
1. Cantarelli MA, Pellerano RG, Marchevsky EJ, Camina JM. (Title of article). Anal Sci, 2011; 27(1): 73-8.
2. Sather BC, Forbes JJ, Starck DJ, Rovers JP. (Title of article). J Am Pharm Asso, 2007; 47(1): 82-5.
3. Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B and Kinzler KW (eds.). The Genetic Basis of Human Cancer, New York; McGraw-Hill: 2002, pp. 93-113.
4. Bard AJ, Faulkner LR. Electrochemical Methods: Fundamentals and Applications. 2nd ed., New York; John Wiley and Sons: 2001.
5. Aviv H, Friedman D, Bar-Ilan A, Vered M. US Patent, US 5496811, 1996.
Manuscripts must be devoid of any forms of plagiarism. They should also have appropriate citations to the related literature in the field.
Review articles should not be more than 25 pages and contain comprehensive coverage of relevant literature. Review articles should preferably be written by scientists who have in-depth knowledge of the topic. All format requirements are similar to those applicable to Research papers. Review articles need not to be divided into sections such as Materials and methods, and Results and discussion, but should definitely have an abstract and introduction.
Proofs will be sent to the corresponding author. Galley proofs should be returned within 72 hours from receipt.
The research and technical communications section of this journal (maximum 3,000 words) is open to interesting results worthy of publication without requiring extensive introduction and discussion. This section should be organized as follows: Abstract, Introduction, Materials and methods, Results and discussion (combined). Not more than 10 references should be provided. Tables, figures and references are to be arranged in the same way as for research papers. Brevity of presentation is essential for this section
For further information, please contact the Editorial Office through:
E-mail: [email protected]
Copyright 2021 Health Biotech and Biopharma